These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30569543)

  • 1. The utility of upper urinary tract urine cytology before and after application of the Paris system.
    Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
    Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
    Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
    Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
    Richardson CJ; Pambuccian SE; Barkan GA
    Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
    Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
    Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
    Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
    Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
    Danakas A; Sweeney M; Cheris S; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
    Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
    J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
    de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
    Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
    Pastorello RG; Barkan GA; Saieg M
    J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved correlation of urinary cytology specimens using The Paris System in biopsy-proven upper tract urothelial carcinomas.
    McIntire PJ; Snow JT; Robinson BD; Rao RA; Goyal A; Heymann JJ; Siddiqui MT
    Cancer Cytopathol; 2018 Jul; 126(7):498-504. PubMed ID: 29927548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
    Cowan ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
    Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
    Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Paris System for Reporting Urinary Cytology reduces atypia rates and does not alter the negative predictive value of urine cytology.
    McIntire PJ; Kilic I; Pambuccian SE; Wojcik EM; Barkan GA
    J Am Soc Cytopathol; 2021; 10(1):14-19. PubMed ID: 33221245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
    Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
    Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of urinary cytology in the setting of upper tract urothelial carcinoma.
    Zhang ML; VandenBussche CJ; Hang JF; Miki Y; McIntire PJ; Peyton S; Vohra P
    J Am Soc Cytopathol; 2021; 10(1):29-35. PubMed ID: 32792229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
    Ma C; Zhang L
    Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
    McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
    Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying the Paris system for reporting urine cytology to challenging cytology cases.
    Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
    Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.